Skip to main content
Erschienen in: Reactions Weekly 1/2007

01.12.2007 | Case report

Anastrozole/letrozole

First report of erythema nodosum: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Jhaveri K, Halperin P, Shin SJ, Vahdat L.Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature. Breast Cancer Research and Treatment 106: 315-318, No. 3, Dec 2007 - USA Jhaveri K, Halperin P, Shin SJ, Vahdat L.Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature. Breast Cancer Research and Treatment 106: 315-318, No. 3, Dec 2007 - USA
Metadaten
Titel
Anastrozole/letrozole
First report of erythema nodosum: 3 case reports
Publikationsdatum
01.12.2007
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2007
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-200711820-00018

Weitere Artikel der Ausgabe 1/2007

Reactions Weekly 1/2007 Zur Ausgabe

Case report

Pregabalin

Case report

Imatinib

Case report

Sertindole